期刊文献+

鲍曼不动杆菌耐药率与抗菌药物用量的相关性分析 被引量:5

The correlation between the resistance rate of Acinetobacter baumannii and antimicrobial consumption
下载PDF
导出
摘要 目的通过对某三级医院2007-2010年抗菌药物的使用情况与鲍曼不动杆菌对各类抗菌药物的耐药性进行相关性分析,探讨鲍曼不动杆菌耐药性变化与抗菌药物用量的相关性,为临床合理用药提供依据。方法回顾性调查某三级医院2007-2010年常用抗菌药物的用药量与用药频度(DDDs),同时统计同期鲍曼不动杆菌对相关抗菌药物的耐药率,应用SAS 8.2统计软件包进行数据分析,用Spearman相关法进行相关性分析。结果鲍曼不动杆菌对亚胺培南的耐药率与碳青霉烯类药物的用量呈显著正相关(r=0.954 6,P<0.01),与亚胺培南用量呈正相关(r=0.849 2,P<0.05);鲍曼不动杆菌对美罗培南的耐药率与其用量呈正相关(r=0.999 2,P<0.05),对阿莫西林-克拉维酸钾的耐药率与其用量呈正相关(r=0.800 5,P<0.05);鲍曼不动杆菌对氨基糖苷类药物、氟喹诺酮类、β-内酰胺酶抑制剂的耐药率与上述药物的用量未见统计学相关(P>0.05)。结论对碳青霉烯类药物的使用应严格掌握适应证,用于鲍曼不动杆菌所致感染时应仅限于重症患者;氨基糖苷类药物阿米卡星与β-内酰胺酶抑制剂头孢哌酮-舒巴坦是治疗鲍曼不动杆菌感染较好的选择。 Objective To analyze the relevance between the consumption of various antimicrobials and antimicrobial re-sistance of Acinetobacter baumanni in a grade three hospital during 2007 -2010 .Methods A retrospective analysis was per-formed to count and sort the defined daily doses (DDDs) and the consumption of various antimicrobials in the hospital between 2007 and 2010 .Meanwhile the resistance rates of Acinetobacter baumanni to different antimicrobials were collected in the same period .Data was analyzed by SAS 8 .2 statistical software package using Spearman correlation method .Results The resistance rate of Acinetobacter baumanni to imipenem was significantly positively correlated with the consumption of carbapenems (r=0 .954 6 ,P〈0 .01) ,it is positively correlated with the dosage of imipenem (r=0 .849 2 ,P〈0 .05) ,it is also significantly posi-tively correlated with the consumption of meropenem (r=0 .999 2 ,P〈0 .05) ,and the consumption of amoxicillin/clavulanate potassium ,respectively(r=0 .800 5 ,P〈0 .05) .There was no correlation between the resistance rate of Acinetobacter bauman-ni and the dosage of aminoglycosides ,fluoroquinolones ,even β-lactamase inhibitors(P〉0 .05) .Conclusion The use of car-bapenems should be correlated with their indications strictly ,only applying to severe infection of Acinetobacter baumanni .The aminoglycosides of amikacin and β-lactamase inhibitors of cefoperazone/sulbactam are the better options to treat A cinetobacter baumanni infection .
出处 《药学实践杂志》 CAS 2015年第5期467-470,共4页 Journal of Pharmaceutical Practice
基金 第二军医大学长海医院"1255"课题--学科特色提升项目(CH125520400)
关键词 鲍曼不动杆菌 耐药性 抗菌药物用量 相关性 A cinetobacter baumannii drug resistance consumption of antibacterial agents correlation
  • 相关文献

参考文献7

  • 1Jiang M, Zhang Z, Zhao S. Epidemiological characteristics and drug resistance analysis of multidrug-resistant Acinetobacter baumannii in a China hospital at a certain time[J]. Pol J Mi- crobiol, 2014,63(3) :275-281. 被引量:1
  • 2Muraki Y, Kitamura M, Maeda Y, et al. Nationwide surveil- lance of antimicrobial consumption and resistance to Pseudo monas aeruginosa isolates at 203 Japanese hospitals in 2010 [J]. Infection,2013,41(2) :415-423. 被引量:1
  • 3马序竹,吕媛.鲍曼不动杆菌对主要抗菌药物耐药机制[J].中国临床药理学杂志,2009,25(1):90-94. 被引量:66
  • 4应春妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212. 被引量:68
  • 5王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 6Bergogne BE,Joly-Guillou ML,Towner KJ. Acinetobacter mi- crobiology, epidemiology, infections, management [ M]. New York.. CRC Press,1996:101-115. 被引量:1
  • 7Bou G,Cervero G,Dominguez MA,et al. Characterization of a nosocomial outbreak caused by a multiresisrant Acinetobacter baumannii strain with a carbapenemhydrolyzing enzyme: high- level carbapenem resistance in A. baumannii is not due solely to the presence of -lactamases[-J]. J Clin Microbiol, 2000,38 : 3299-3305. 被引量:1

二级参考文献82

  • 1顾兵,童明庆.整合子与细菌耐药[J].临床检验杂志,2005,23(3):226-229. 被引量:46
  • 2Naas T, Bogaerts P, Bauraing C, et al. Emergence of PER and VEB extended - spectrum betalactamases in Acinetobacter baumannii in Belgium[J]. JAntimicrob Chemother, 2006; 58:178 182. 被引量:1
  • 3Poirel L, Cabanne L, Marque S,et al. Genetic environment and expression of the extended - spectrum beta - lactamase blaPER - 1 gene in gram - negative bacteria. Antimicrob [ J ]. Agents Chemother, 2005 ; 49:1708 -1713. 被引量:1
  • 4Pasteran F, Rapoport M, Jones N, et al. Emergence of PER - 2 and VEB - 1 a in Acinetobacter baumannii strains in the Americas. Antimicrob[J]. Agents Chemother, 2006 ;50:3222 - 3224. 被引量:1
  • 5Celenza G,Pellegrini C, Caccamo M, et al. Spread of bla(CTX- Mtype) and bla( PER -2 ) beta -lactamase genes in clinical isolates from Bolivian hospitals[ J]. J Antimicrob Chemother, 2006 ;57:975 - 978. 被引量:1
  • 6Walsh TR. The emergence and implications of metallo - beta - lactamases in Gram - negative bacteria [J]. Clin Microbiol Infect, 2005 ; 11 (Suppl. 6) :S2 - S9. 被引量:1
  • 7Walsh TR, Toleman MA, Poirel L, et al. Metallo - lactamases: the quiet before the storm [ J ] ? Clin Microbiol Rev,2005 ; 18:306 - 325. 被引量:1
  • 8Watanabe M, Iyobe S, Inoue M, et al. Transferable imipenem resistance in Pseudomonas aentginosa. Antimicrob [ J]. Agents Chemother, 1991 ;35:147 - 151. 被引量:1
  • 9Lee K, Ha GY, Shin BM, et al. Metallo - beta - lactamase - producing Gram - negative bacilli in Korean Nationwide Surveillance of Antimicrobial Resistance Group Hospitals in 2003 : continued prevalence of VIM - producing Pseudomonas spp. and increase of IMP - producing Acinetobacter spp. [ J ]. Diagn Microbiol Infect Dis, 2004 ; 50 : 51 - 58. 被引量:1
  • 10Gales AC, Tognim MC, Reis AO, et al. Emergence of an IMP - like metallo -β- enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital [ J ]. Diagn Microbiol Infect Dis, 2003; 45:77 - 79. 被引量:1

共引文献147

同被引文献60

  • 1王艳丽,黄茂,梅亚宁,殷凯生.鲍曼不动杆菌对喹诺酮类药物的耐药机制研究[J].中国感染与化疗杂志,2008,8(4):266-270. 被引量:24
  • 2戴春梅,郑兰香,陈辉.129株鲍曼不动杆菌所致医院感染的耐药性分析[J].实用预防医学,2006,13(1):62-63. 被引量:25
  • 3应春妹,翁文浩.鲍曼不动杆菌多重耐药机制研究进展[J].检验医学,2007,22(2):208-212. 被引量:68
  • 4薛红漫,李红玉,苏文捷.鲍曼不动杆菌医院感染状况及耐药性分析[J].中国热带医学,2007,7(10):1906-1907. 被引量:13
  • 5Afridi SA, Alvi HF, Lodhi FS, et al. Successful treatment of muhidrug- resistant Acinetobacter baumannii blisters on the knee[J]. J Ayub Med Coil Abbottabad, 2015, 27(2):476-478. 被引量:1
  • 6Ababneh M, Harpe S, Oinonen M, et al.Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship[J]. Infect Control Hosp Epidemiol, 2012, 33(6): 594-601. DOI: 10.1086/665724. 被引量:1
  • 7Sousa D, Castelo-Corral L, Guti 6 rrez-Urb 6 n JM, et al. Impact of ertapenem use on Pseudomonas aeruginosa and Acinetobacter baumannii imipenem susceptibility rates: collateral damage or positive effect on hospital ecology? [J]. J Antimicrob Chemother, 2013, 68(8): 1917-1925. DOI: 10.1093/jac/dkt091. 被引量:1
  • 8Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter haumannii: Mechanisms and epidemiology [J]. Int J Antimicrob Agents, 2015, 45(6): 568-585. 被引量:1
  • 9Shrestha S, Tada T, Miyoshi-Akiyama T, et al. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage[J]. Int J Antimicrob Agents, 2015, 46(5): 526-531. 被引量:1
  • 10Alagesan M, Gopalakrishnan R, Panchatcharam SN, et al. A decade of change in susceptibility patterns of Gram-negative blood culture isolates: a single center study[J]. Germs, 2015, 5(3): 65-77. 被引量:1

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部